AICZA and AlC2B are closely related genes encoding components of the receptors for murine interleukin-3 (IL-3) (AIC2A) and granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-5 (AICZB). We have studied the parallel regulation of expression of these genes in erythroid and myeloid progenitor cell lines. AlCPA and AlC2B transcription was transiently induced in these cells in response to a variety of hematopoietic growth factors, including erythropoietin (EPO), monocyte-CSF, IL-3, GM-CSF, and stem cell factor (SCF or kit ligand). Run-on assays established that the increase occurred mainly at the transcriptional level. Immunoprecipitation experiments confirmed that the increase in messenger RNA ROLIFERATION and differentiation of hematopoi-P etic cells are mediated by a hierarchy of general and specialized hematopoietic growth factors (HGFs).' Among these, interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) have been shown to act primarily on early progenitors: whereas erythropoietin (EPO), granulocyte-CSF (G-CSF), and monocyte-CSF (M-CSF) appear to act at later stages of differentiation.' AS multiple HGF receptors are displayed on the surface of progenitor cells, ordered differentiation requires that expression and activation of the receptors be specific and tightly regulated. Walker et a13 reported that IL-3 could downmodd a t e receptors for GM-CSF, M-CSF, or G-CSF on mouse bone marrow cells. Likewise, GM-CSF could down modulate M-CSF and G-CSF receptors. The later-acting growth factors M-CSF and G-CSF modulated the expression of GM-CSF and M-CSF receptors only when present in high. concentrations. This hierarchical pattern of HGF-induced receptor modulation suggested a model for growth factor regulation of differentiation. Although it provided an explanation for the capacity for IL-3 to promote differentiation in diverse lineages, it did not fully explain the synergism of action that early and late-acting factors have on progenitor cells. Indeed, G-CSF and IL-6, in combination with IL-3, have been shown to enhance the ability of progenitor cells to form colonies in vitro!,5 Similarly, EPO plus IL-3, and G-CSF plus IL-3 or plus GM-CSF act synergistically in erythroid colonies and granulocyte colony assays, respectively.6 Little is known about the mechanisms mediating these synergistic effects, but it is believed that HGFs can influence the expression and activation of nonisologous receptors.
P etic cells are mediated by a hierarchy of general and specialized hematopoietic growth factors (HGFs).' Among these, interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) have been shown to act primarily on early progenitors: whereas erythropoietin (EPO), granulocyte-CSF (G-CSF), and monocyte-CSF (M-CSF) appear to act at later stages of differentiation.' AS multiple HGF receptors are displayed on the surface of progenitor cells, ordered differentiation requires that expression and activation of the receptors be specific and tightly regulated. Walker et a13 reported that IL-3 could downmodd a t e receptors for GM-CSF, M-CSF, or G-CSF on mouse bone marrow cells. Likewise, GM-CSF could down modulate M-CSF and G-CSF receptors. The later-acting growth factors M-CSF and G-CSF modulated the expression of GM-CSF and M-CSF receptors only when present in high. concentrations. This hierarchical pattern of HGF-induced receptor modulation suggested a model for growth factor regulation of differentiation. Although it provided an explanation for the capacity for IL-3 to promote differentiation in diverse lineages, it did not fully explain the synergism of action that early and late-acting factors have on progenitor cells. Indeed, G-CSF and IL-6, in combination with IL-3, have been shown to enhance the ability of progenitor cells to form colonies in vitro!,5 Similarly, EPO plus IL-3, and G-CSF plus IL-3 or plus GM-CSF act synergistically in erythroid colonies and granulocyte colony assays, respectively. 6 Little is known about the mechanisms mediating these synergistic effects, but it is believed that HGFs can influence the expression and activation of nonisologous receptors.
We have investigated whether expression of components of the IL-3 and GM-CSF receptors (AIC2A and AIC2B, respectively) could be regulated by the action of the later-acting HGFs EPO and M-CSF, as well as by the earlier acting HGFs IL-3 and GM-CSF and by kit ligand, which appears to function in both the early and late stages of hematopoie~is.~ AIC2A encodes the low-affinity binding chain of the mouse IL-3 receptor! whereas the 95% homologous AIC2B gene9 encodes a shared subunit that combines with the low-affinity binding chains of GM-CSF expression resulted in augmented synthesis of both AIC2A and AlC2B proteins, and binding studies further showed these proteins to be functional. We observed a fourfold increase in low-affinity IL-3 sites in an erythroid precursor cell line stimulated with EPO, and a threefold increase in GM-CSF high-affinity sites in a myeloid cell line stimulated with IL-3. In addition, we showed that the increase in the IL-3 receptor chain AlC2A in the erythroid precursor cell line correlated with the ability of IL-3 to exert a cooperative effect with EPO in the induction of p-globin in these cells.
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and IL-5 receptors and confers high-affinity binding.I0-l2 We examined expression of AIC2A and AIC2B in a murine erythroid precursor cell line, J2E,13 and a phagocytic precursor cell line, 32D.14 We found that messenger RNA (mRNA) expression of both AIC2A and AIC2B transiently increased when cells were stimulated by EPO and M-CSF, as well as by several other growth factors. This transcriptional induction directly affected HGF receptor populations on the cell surface. In J2E cells, upmodulation of expression led to an increase in low-affinity receptors to IL-3, attributable to AIC2A expression. Analogously, in 32D cells, stimulated AIC2B gene expression resulted in an increased number of GM-CSF high-affinity binding sites. Furthermore, costimulation of J2E cells with EPO and IL-3 enhanced their ability to synthesize p-globin, indicating that these cells were pushed down a pathway towards erythroid differentiation. Interestingly, longer treatment of J2E cells with EPO eventually led to destabilization of AIC2A and AIC2B transcripts, consistent with the notion that multipotential growth factor receptors were no longer needed.
We suggest that regulation of AIC2A and AIC2B genes by HGFs may be central to the synergistic effects of IL-3 and GM-CSF in combination with later-acting growth factors, such as EPO, M-CSF, and G-CSF, and may operate in the regulation of normal hematopoietic differentiation.
DNA and RNA Probes
Total RNA was isolated from BaF3 cells, and polyA+ RNA was prepared. Two micrograms of polyA+ mRNA was subjected to first-and second-strand cDNA synthesis according to the manufacturer's instructions (GIBCO-BRL, Grand Island, NY). An AIC2A-specific 2.67-kb fragment was amplified by PCR from total BaF3 cDNA. This fragment starts 27 nucleotides upstream of the initiating ATG and ends 6 nucleotides past the termination codon. 8 The 5' primer (5'-GGGCTCGAGTCCTGTGCAGCCAC-C A A A A G -3 ' ) a n d 3'-primer ( 5 ' -G G G C T C G A G G -TAGTCCTAATACTTTAGGG-3') includedB0 I restriction sites for subcloning into the expression vector, pXM. The identity of the amplified fragment was confirmed by partial sequencing and IL-3 binding experiments with COS cells transfected with this DNA.
v-myc and EPO receptor @PO-I?) DNAs. The v-myc (OK10) DNA was a 2.5-kb BamHI fragment isolated from MMCV virus DNA.I5 The EPO-R cDNA was a kind gift of Dr Alan D'Andrea (Dana-Farber Cancer Institute). 16 For AIC2, a SacI-Sau3AI fragment (position 410 to 536 in AIC2A CDNA)~ was isolated and inserted into the BamHI-Sac I sites of the SP72 polylinker. Antisense probe was synthesized with SP6 polymerase after linearization with EcoRI. DNA for the P-globin probe was kindly provided by Richard Mulligan (Whitehead Institute, Cambridge, MA)." The DNA was linearized with EcoRI and antisense RNA was obtained with SP6 polymerase.
AIC2A DNA.
RNase protection probes.
Cell Stimulation, RNA Extraction, and Anabsis
Total RNA was obtained by the guanidinium isothiocyanate (GITC) method after centrifugation through cesium chloride.'* Northem blot. Fifteen micrograms of total RNA was fractionated on a 1% agarose formaldehyde gel, transferred to nitrocellulose filter, and hybridized as previously described.19
Twenty-five micrograms of total RNA was resuspended in 31 JLL of hyb-buffer (80% [vol/vol] formamide, 40 mmol/L PIPES pH 6.4,400 mmol/L NaCI, 1 mmol/L EDTA) containing the indicated 32P-labeled RNA probe. Hybridization, digestion with RNase A and T1, and digestion with proteinase K were performed as describedJO Samples were resuspended in formamide-dye mix, denatured at 90"C, and loaded on a 6% Tris borate EDTA (TBE) urea/acrylamide gel.
RNA extraction.
RNase protection assay.
Nuclear Run-on Assay J2E cells ( l e ) were incubated for 0,4, and 24 hours with EPO and then lysed in 30 mL of lysis buffer (50 mmol/L Tris, pH 7.5,100 mmol/L KCI, 5 mmol/L MgC12,15% glycerol, 1 mmol/L dithiothreitol [DlT] , and 0.5% NP-40). Nuclei were resuspended in 200 pL of lysis buffer that lacked NP-40, and were used immediately for RNA extension in the presence of CY-~~P-UTP as previously described.z1 Equal counts of the labeled RNAs were used for hybridization to filters carrying 0.5 kg of denatured AIC2A, MMCV (v-myc),ls pUC, and EPO-R16 DNA. Hybridization was performed at 47°C for 48 hours. Filters were washed, treated for 20 minutes at 25°C with 10 p,g/mL of RNase A in 2x SSC, and autoradiographed for 2 days.
Metabolic Labeling and Immunoprecipitation
J2E cells were placed in methionine-free medium for 1 hour before labeling for 2 hours with 250 pCi of 35S-methionine (New England Nuclear [NEN], Boston, MA). Cells extracts were obtained as describedJ2 Aliquots were immunoprecipitated with a rat monoclonal antibody (MoAb), 18H6-14,23 that recognizes both AIC2A and AIC2B proteins (18H6-14 was a generous gift of Dr R. Devos, Roche Research, Gent, Belgium). Goat antirat antibody was also added to improve binding of the immune complex to protein A-Sepharose beads. Bound immune complexes were washed and separated on a 6% sodium dodecyl sulfate (SDS) polyacrylamide gel. Gels were dried and treated with EnHance (NEN) and autoradiographed for 2 days.
Growth Factor Iodination and Receptor Binding
Carrier-free murine IL-3 and GM-CSF (R&D Systems, Minneapolis, MN) were iodinated by the iodine monochloride methodx to a specific activity of 2.2 to 2.6 x 106 cpm/kg of protein. Cell surface receptor expression was measured by incubating cells with labeled ligand in RPMI, containing 5% FCS, 30 mmol/L HEPES (pH 7.4), and 0.2% sodium azide for 5 hours at 4°C. Cells were then centrifuged through FCS and radioactivity was measured in the pellets. The contribution of nonspecific binding (never greater than 15% of the total binding) was determined by incubating the sample in a 100-fold excess of unlabeled ligand for 30 minutes before adding the iodinated ligand.
RESULTS
The effect of hematopoietic growth factors on IL-3 receptor (IL3R) gene expression was studied initially in the murine erythroid progenitor cell line J2E, which express a functional EPO-R.13 Although these cells are not factordependent, their growth under serum-free conditions was enhanced if IL-3 was added to the medium, showing that these cells expressed a functional IL-3R.
To investigate whether EPO treatment would affect expression of the I L 3 R gene, cells were treated with EPO and steady-state AIC2A and AIC2B mRNA was measured after various intervals by an RNase protection assay. A probe, complementary to AIC2A and derived from a region where the AIC2A and AIC2B genes differed at several contiguous residues, was used to discriminate between transcripts of the two genes. As shown in Fig 1, J2E cells expressed constitutively higher levels of AIC2B mRNA than of AIC2A. However, there was a marked increase in both AIC2A mRNA (127-nt protected fragment) and AIC2B mRNA (90-nt protected fragment) after 5 hours of by RNase protection analysis. RNA extracted from J2E cells unstimuIated or stimulated with EPO for 5,24, or 48 hours was hybridized with a riboprobe (Materials and Methods) that discriminates between the two AIC2 transcrlpts. AlC2A (127n) represents the fully AIC2A-protected fragment. mRNA from AIC2B protects a smaller size fragment (son). The 76n band may result from an existing single base change between AIC2A and AIC2B or may be the product of an alternative splice. As a control, tRNA was hybridized with the same riboprobe and processed identically to the other samples.
EPO treatment. This increase was transient, and expression of both genes decreased below basal levels at 24 hours and continued to decrease with longer treatment (48 hours). These results were confirmed by Northern blot analysis using oligonucleotides specific for AIC2A and AIC2B (data not shown). The transient upregulation of the AIC2A and AIC2B genes was not inhibited by cycloheximide (10 mg/mL) or hydroxyurea (1 mmol/L; data not shown). In addition to the two expected protected fragments, we detected a third band at 76 nt. The identity of this band is at present unclear, but it may arise from AIC2B. Indeed, in addition to the main area in our probe where AIC2A and AIC2B genes are different, there is a single nucleotide difference between the two genes, 76 bases from the start of the protected sequence. Alternatively, the protected fragment could arise from a differentially spliced RNA.
Nuclear run-on experiments were performed to determine whether the changes in AIC2A and AIC2B mRNA expression in J2E cells treated with EPO were transcriptional or posttranscriptional. As shown in Fig 2, the transcription rate of the AIC2A/AIC2B gene was significantly increased after 5 hours of EPO treatment, while little change in the rate of v-myc or EPO-R transcription was observed. Interestingly, the rate of transcription for the AIC2A/B gene was still elevated after 24 hours of EPO treatment. This contrasts with the barely detectable level of steady-state mRNA detected at 24 hours for these genes (Fig 1) .
We next examined whether the increase in transcription led to an increase in AIC2A and AIC2B proteins. J2E cells, either unstimulated or stimulated with EPO for 6 hours, were metabolically labeled with 3% methionine. Cell extracts were immunoprecipated with an MoAb reacting with both AIC2A and AIC2B proteins. As shown in Fig 3B, EPO treatment resulted in increased synthesis of both AIC2A and AIC2B proteins. Consistent with the mRNA data, the AIC2B gene product was more abundant than that of AIC2A. The identity of the upper band as AIC2B protein was inferred from the immunoprecipitation pattern obtained with a Ba/M cell extract that had been treated with an MoAb specific for AIC2A protein or with the same antibody used for the J2E cell extracts (Fig 3A) .
To dctermine whether the increase in protein synthesis led to the expression of functional proteins on the surface, binding experiments with iodinated I L 3 were performed.
J2E cells were stimulated with EPO (2 U/mL) or mock treated, and binding of lZsI-IL-3 was measured after 12 hours to allow receptor transit to the cell surface. As shown in Table 1 , we measured a 3.5-fold increase in the number of low-affinity sites as well as a slight increase in the total number of high-affinity sites.
Because J2E cells are known to respond to EPO and MoAb that reacts with both AIC2A and AiC2B proteins.n (E) Untreated J2E cells were placed in methionine-free medium for 1 hour and subsequently labeled with 250 pCi of JY4 methionine for 2 hours. Cells treated with €PO (6 hours) were methionine-starved and labeled in the same way, starting 3 hours before the end of €PO stimulation. After labeling, cell extracta were immunoprecipitated with MoAb 18H6-14.n Immunoprecipitations In (A) and (E) represent separate experiments.
resemble erythroid pr~genitors,'~ we examined whether the transient increase in AIC2A and AIC2B gene expression caused by EPO was restricted to these cells. To address this question, we chose a derivative of the IL-Mependent murine cell line BaF325 into which the EPO-R had been introduced. This clone, BaF3/EPO-R,Z6 is dependent on either IL-3 or EPO for growth. Transcription of both AIC2A and AIC2B was markedly augmented after 5 hours of EPO stimulation, but returned to basal level when the cells were treated with EPO for 24 hours (Fig 4) . J2E cells were treated with EPO for 12 hours. Cells were then incubated with iodinated IL-3 in RPMl for 5 hours at 4%. After labeling, cells were centrifuged through FCS and the pellet counted. Nonspecific binding was determined by incubating the sample in a 100-fold excess of unlabeled ligand for 30 minutes before adding the iodinated ligand. Representative data from one experiment are shown. Although slight differences in the calculated number of sites were found in three other experiments, the same overall stimulation fold in receptor number and similar affinities were observed after treatment with €PO. Low affinity kd was 10-9; high affinity kd was lo-".
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We next tested whether AIC2 gene expression in J2E cells was under the specific regulation of EPO, or whether a similar effect could be observed with other hematopoietic growth factors such as SCF (kit ligand) or To insure that trace amounts of EPO (present in FCS) did not interfere with our analysis, the cells were switched to a defined medium that lacked serum. Under these conditions, cells could proliferate for up to 3 days without any adverse effect (data not shown). For these experiments. the cells were maintained for 1 day in defined medium, and were subsequently stimulated with SCF or IL-3 for 5 hours. After stimulation, RNA was isolated and analyzed by Northern blot with a probe recognizing both AK2A and AIC2B. As shown in Fig 5, the effect was not restricted to EPO, and could be achieved with either SCF or To examine regulation of AIC2A and AlC2B by M-CSF or GM-CSF, we studied the effect of HGF stimulation on 32D cells. These cells can differentiate into phagocytic lineages and express M-CSF and GM-CSF receptors. Accordingly, 32D cells were washed free of IL-3 and resuspended for 2 hours in the absence of all growth factors. At that time, either IL-3, M-CSF, or GM-CSF was added to the culture for 5 hours before total cellular RNA was isolated and analyzed by Northern blot. In all cases, we observed a twofold to threefold increase in mRNA expression for AIC2A and AIC2B (data not shown). To test whether this increase led to an increase in the AIC2B protein on the cell surface, binding experiments with analyzed by Notthem blotting. J2E calls were grown In serum-free condklons for 24 hours and then the different growth factors were added for 5 hours. The nitrocellulose finer was hybridized with a cDNA probe that recognizes both comigrating AlC2 transcripts.* IZSI-GM-CSF were performed after I L 3 stimulation. 32D cells were factor-deprived for 2 hours, and were subsequently stimulated with IL-3 for 12 hours. Cells were harvested and binding at equilibrium with IZSI-GM-CSF was measured in the presencc or absence of cold competitor (Table 2 ). High-affinity GM-CSF sites increased 2.4-fold after stimulation. Low-affinity GM-CSF sites were not determined.
Because both phagocytic and erythroid precursor cells transiently increase the expression of components of the IL-3 and GM-CSF rcceptors in response to appropriate HGFs, we next investigated whether this effect might have functional significancc. To do so, we studied p-globin induction in J2E cells. The previous studies of Klinken et all3 had shown that J2E cells gradually increase p-globin expression when incubated in the presence of EPO. Because our studies show that EPO increases the number of low-affinity 1L-3 receptors and IL-3 is known to enhance differentiation of erythroid precursors, we tested whether addition of IL-3 to EPO during the incubation would augment p-globin synthcsis (Fig 6) . The results show that, although EPO or IL-3 alone could induce p-globin mRNA (Fig 6, lanes 3 and 4) . greater activation was observed when EPO and IL-3 were prcscnt together (Fig6, lanc 5) . DISCUSSION Walker et a13 showed that IL-3 downregulates the receptors for the lineage-specific HGFs, M-CSF and G-CSF. In this study, we invcstigated the reverse aspect: expression of homologous componcnts of the murine IL-3 and GM-CSF 
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1.9 x 10-10 1.9 x 10-10 ~ 32D cells were treated with IL-3 for 12 hours. After this period, cells were incubated with labeled GM-CSF in RPMl for 5 hours at 4°C. Cells were then centrifuged through FCS and the pellet counted. A representative experiment is shown. Although slight variations in the number of sites were found in another experiment, the same overall stimulation fold in high-affinity receptors and similar-affinity constants were obreceptors in response to later-acting HGFs. The murine AIC2A gene encodes a low-affinity binding chain of the IL-3R,R whereas the 95% homologous AICZB geneQ encodes a subunit that converts the low-affinity GM-CSF or IL-5R to high affinity.lBIZ J2E cells were selected as our initial model system, as this erythroid precursor cell line was described to undergo limited differentiation in response to EPO.I3 We reasoned that as J2E cells acquired a more differentiated phenotype, expression of the IL-3R AIC2A gene might be lost.
Although our expectations turned out to be correct, we observed that the initial response was a transient increase in AIC2A gene expression in response to EPO. The increase in steady-state mRNA correlated with an increased rate of transcription of the AIC2A gene, was dose-dependent, did not require new protein synthesis, and occurred when S phase was prevented by hydroxyurea. Furthermore, the transient activation was seen with EPO, SCF, or IL-3 and was not restricted to the J2E cell line. Similar increases were observed in the murine cell line BaF3-EPOR in response to EPO, and in the phagocytic progenitor clone 32DclU in response to M-CSF, GM-CSF, or IL-3. The increase in AIC2A expression was accompanied by an increase in AIC2B expression in all cells tested. This is not unexpected as expression of AIC2A and AICZB genes has been reported to be tightly linked?
The influence of these factors on AIC2A and AIC2B For personal use only. on July 15, 2017. by guest www.bloodjournal.org From gene transcription has functional significance. Metabolic labeling of J2E cells stimulated for 6 hours with EPO showed that the increase in AIC2A and AIC2B gene expression was accompanied by a functional increase in protein synthesis. EPO-stimulated J2E cells expressed a higher number of IL-3 low-affinity binding sites on their cell surface, and IL-3-stimulated 32D cells displayed an increased number of GM-CSF high-affinity binding sites.
Upmodulation of AIC2A and AIC2B gene expression by later-acting HGFs in precursor cells may be part of a more general phenomenon. Expression of several other HGF receptors has been shown to be affected by binding of noncognate HGFS."-~~ However, there is some underlying specificity in the response. In contrast to what we observed for AIC2A and AIC2B expression, EPO or IL-3 treatment had no effect on the expression of the EPO receptor in J2E cells.
The remarkable crossregulation between HGFs and their receptors is intriguing in the light of the recent finding that the human GM-CSF, IL-3, and IL-5 receptors share a common subunit that combines with specific low-affinity binding chains to convert them into high-affinity recept o r~.~~,~~ As already mentioned, AIC2A encodes the lowaffinity binding chain for IL-3 and AIC2B encodes the common subunit conferring high affinity to the GM-CSF and IL-5 receptors. Increasing AIC2B protein thus affects the number of the two high-affinity receptors if their respective low-affinity binding chains are expressed. This may have important implications for progenitor cells, as occupancy of a small number of high-affinity receptors is sufficient for the biologic effect of GM-CSF.l In addition, upmodulation of receptors after HGF exposure may contribute to the synergism of action between different HGFs. Cotreatment of J2E cells with EPO and IL-3 leads to maximal activation of P-globin gene expression. It is possible that the increase in AIC2A expression in response to EPO may be related to this observation. Although the number of IL-3 high-affinity sites was only marginally affected in J2E cells treated with EPO, the increase in AIC2A protein expression alone might have been sufficient to enhance the probability for each cell to be simultaneously activated by both factors.
In contrast to the increase in AIC2A and AIC2B mRNAs that followed a short incubation time with EPO, we observed that prolonged treatment of J2E cells with this factor dramatically diminished the steady-state level of AIC2A/B mRNA. In this case, regulation was posttranscriptional, presumably through message destabilization. Such diminution of expression was not observed after SCF or IL-3 treatment of J2E cells (data not shown). Thus, it is likely that destabilization of the AIC2A/B mRNA in 32E cells is somehow linked to differentiation of these cells in response to EPO. This conclusion is supported by the observation that prolonged treatment of BaF3-EPOR cells (which do not appear to differentiate in response to EPO) does not depress expression of AIC2A/B mRNAs below that of basal level. There is a precedent for message destabilization of a receptor through the action of another HGF. Gliniak and Rohrschneider isolated a variant of the factor-dependent murine progenitor FDCP cell line that expressed high levels of the M-CSF receptors and proliferated in the presence of this factor.32 Addition of IL-3 to this cell clone resulted in the rapid destabilization of the M-CSF receptor mRNA and the disappearance of its protein from the cell surface. This observation provided a molecular explanation for the phenomenon described by Walker et aL3 Interestingly, the effect was observed even in the presence of M-CSF, and led the investigators to postulate that the action of IL-3 was dominant over that of M-CSF for expression of the M-CSF receptor.
Regulation of expression of HGFs in a stage-and cell-specific manner has long been recognized. In addition, expression of some of the receptor genes can be transiently affected by the action of other growth factors. This general response to a broad range of growth and differentiation signals, in concert with the regulated expression of the HGFs themselves, may allow a rapid recruitment of mature cells from a progenitor pool in response to injury or increased demands. A full understanding of this type of regulation, both at the transcriptional and posttranscriptional level, will require the identification of the promoter elements of the receptor genes as well as the sequences responsible for the rapid degradation of their mRNAs.
